{"disease":{"id":"dementia-with-lewy-bodies-dlb","name":"dementia with lewy bodies dlb"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07314190","title":"Retrospective Observational Study of Blood-based Biomarkers in the Diagnosis and Monitoring of Patients With a Neurodegenerative Disease or Mental Disorder","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":1799,"lead_sponsor_name":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","has_results":false},{"nct_id":"NCT07239843","title":"Prospective Observational Study of the Relationship Between Sociodemographic Factors, Blood-based Biomarkers and Psychiatric Symptoms in Neurodegenerative Diseases and Mental Disorders","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":1310,"lead_sponsor_name":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","has_results":false},{"nct_id":"NCT03030586","title":"ADDIA Proof-of-Performance Clinical Study","phase":"","overall_status":"COMPLETED","enrollment_count":821,"lead_sponsor_name":"Amoneta Diagnostics SAS","has_results":false},{"nct_id":"NCT07166744","title":"Contribution of Pathological Alpha-synuclein as a Diagnostic Biomarker for Dementia With Lewy Bodies","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":286,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT04001517","title":"Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia With Lewy Bodies","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":91,"lead_sponsor_name":"EIP Pharma Inc","has_results":true},{"nct_id":"NCT07240805","title":"Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"BioSensics","has_results":false},{"nct_id":"NCT06815965","title":"A Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"EIP Pharma Inc","has_results":false},{"nct_id":"NCT04055532","title":"Biomarkers in Neurodegenerative Diseases","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"University of Minnesota","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}